 | • レポートコード：GIR-2104Z05401 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ファブリー病治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ファブリー病治療の種類別市場規模（酵素補充療法（ERT）、シャペロン治療、基質減少療法（SRT）、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ファブリー病治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi S.A.、Takeda、Amicus Therapeutics Inc.、ISU Abxis Co Ltd.、JCR Pharmaceuticals Co Ltd.、Protalix Biotherapeutics Inc.、Idorsia Pharmaceuticals Ltd.、Avrobio Inc.、Greenovation Biotech GmbH、Moderna Therapeutics Inc.、Green Cross Pharma Pte Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：酵素補充療法（ERT）、シャペロン治療、基質減少療法（SRT）、その他 ・用途別分析2016年-2026年：病院、診療所、その他 ・ファブリー病治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ファブリー病治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ファブリー病治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ファブリー病治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ファブリー病治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Fabry Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Fabry Disease Treatment size is estimated to be USD 1880.8 million in 2025 from USD 1535 million in 2019, with a change XX% between 2019 and 2020. The global Fabry Disease Treatment market size is expected to grow at a CAGR of 5.2% for the next five years.
Market segmentation
Fabry Disease Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Enzyme Replacement Therapy (ERT)
Chaperone Treatment
Substrate Reduction Therapy (SRT)
Others
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
Sanofi S.A.
Takeda
Amicus Therapeutics Inc.
ISU Abxis Co Ltd.
JCR Pharmaceuticals Co Ltd.
Protalix Biotherapeutics Inc.
Idorsia Pharmaceuticals Ltd.
Avrobio Inc.
Greenovation Biotech GmbH
Moderna Therapeutics Inc.
Green Cross Pharma Pte Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Fabry Disease Treatment
1.2 Classification of Fabry Disease Treatment by Type
1.2.1 Overview: Global Fabry Disease Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Fabry Disease Treatment Revenue Market Share by Type in 2020
1.2.3 Enzyme Replacement Therapy (ERT)
1.2.4 Chaperone Treatment
1.2.5 Substrate Reduction Therapy (SRT)
1.2.6 Others
1.3 Global Fabry Disease Treatment Market by Application
1.3.1 Overview: Global Fabry Disease Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Fabry Disease Treatment Market Size & Forecast
1.5 Global Fabry Disease Treatment Market Size and Forecast by Region
1.5.1 Global Fabry Disease Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Fabry Disease Treatment Market Size by Region, (2016-2021)
1.5.3 North America Fabry Disease Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Fabry Disease Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Fabry Disease Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Fabry Disease Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Fabry Disease Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Fabry Disease Treatment Market Drivers
1.6.2 Fabry Disease Treatment Market Restraints
1.6.3 Fabry Disease Treatment Trends Analysis
2 Company Profiles
2.1 Sanofi S.A.
2.1.1 Sanofi S.A. Details
2.1.2 Sanofi S.A. Major Business
2.1.3 Sanofi S.A. Fabry Disease Treatment Product and Solutions
2.1.4 Sanofi S.A. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Sanofi S.A. Recent Developments and Future Plans
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Fabry Disease Treatment Product and Solutions
2.2.4 Takeda Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Takeda Recent Developments and Future Plans
2.3 Amicus Therapeutics Inc.
2.3.1 Amicus Therapeutics Inc. Details
2.3.2 Amicus Therapeutics Inc. Major Business
2.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Product and Solutions
2.3.4 Amicus Therapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Amicus Therapeutics Inc. Recent Developments and Future Plans
2.4 ISU Abxis Co Ltd.
2.4.1 ISU Abxis Co Ltd. Details
2.4.2 ISU Abxis Co Ltd. Major Business
2.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Product and Solutions
2.4.4 ISU Abxis Co Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 ISU Abxis Co Ltd. Recent Developments and Future Plans
2.5 JCR Pharmaceuticals Co Ltd.
2.5.1 JCR Pharmaceuticals Co Ltd. Details
2.5.2 JCR Pharmaceuticals Co Ltd. Major Business
2.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Product and Solutions
2.5.4 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 JCR Pharmaceuticals Co Ltd. Recent Developments and Future Plans
2.6 Protalix Biotherapeutics Inc.
2.6.1 Protalix Biotherapeutics Inc. Details
2.6.2 Protalix Biotherapeutics Inc. Major Business
2.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Product and Solutions
2.6.4 Protalix Biotherapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Protalix Biotherapeutics Inc. Recent Developments and Future Plans
2.7 Idorsia Pharmaceuticals Ltd.
2.7.1 Idorsia Pharmaceuticals Ltd. Details
2.7.2 Idorsia Pharmaceuticals Ltd. Major Business
2.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Product and Solutions
2.7.4 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Idorsia Pharmaceuticals Ltd. Recent Developments and Future Plans
2.8 Avrobio Inc.
2.8.1 Avrobio Inc. Details
2.8.2 Avrobio Inc. Major Business
2.8.3 Avrobio Inc. Fabry Disease Treatment Product and Solutions
2.8.4 Avrobio Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Avrobio Inc. Recent Developments and Future Plans
2.9 Greenovation Biotech GmbH
2.9.1 Greenovation Biotech GmbH Details
2.9.2 Greenovation Biotech GmbH Major Business
2.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Product and Solutions
2.9.4 Greenovation Biotech GmbH Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Greenovation Biotech GmbH Recent Developments and Future Plans
2.10 Moderna Therapeutics Inc.
2.10.1 Moderna Therapeutics Inc. Details
2.10.2 Moderna Therapeutics Inc. Major Business
2.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Product and Solutions
2.10.4 Moderna Therapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Moderna Therapeutics Inc. Recent Developments and Future Plans
2.11 Green Cross Pharma Pte Ltd.
2.11.1 Green Cross Pharma Pte Ltd. Details
2.11.2 Green Cross Pharma Pte Ltd. Major Business
2.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Product and Solutions
2.11.4 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Green Cross Pharma Pte Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Fabry Disease Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Fabry Disease Treatment Players Market Share
3.2.2 Top 10 Fabry Disease Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Fabry Disease Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Fabry Disease Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Fabry Disease Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Fabry Disease Treatment Revenue Market Share by Application (2016-2021)
5.2 Fabry Disease Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Fabry Disease Treatment Revenue by Type (2016-2026)
6.2 North America Fabry Disease Treatment Revenue by Application (2016-2026)
6.3 North America Fabry Disease Treatment Market Size by Country
6.3.1 North America Fabry Disease Treatment Revenue by Country (2016-2026)
6.3.2 United States Fabry Disease Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Fabry Disease Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Fabry Disease Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Fabry Disease Treatment Revenue by Type (2016-2026)
7.2 Europe Fabry Disease Treatment Revenue by Application (2016-2026)
7.3 Europe Fabry Disease Treatment Market Size by Country
7.3.1 Europe Fabry Disease Treatment Revenue by Country (2016-2026)
7.3.2 Germany Fabry Disease Treatment Market Size and Forecast (2016-2026)
7.3.3 France Fabry Disease Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Fabry Disease Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Fabry Disease Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Fabry Disease Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Fabry Disease Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Fabry Disease Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Fabry Disease Treatment Market Size by Region
8.3.1 Asia-Pacific Fabry Disease Treatment Revenue by Region (2016-2026)
8.3.2 China Fabry Disease Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Fabry Disease Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Fabry Disease Treatment Market Size and Forecast (2016-2026)
8.3.5 India Fabry Disease Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Fabry Disease Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Fabry Disease Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Fabry Disease Treatment Revenue by Type (2016-2026)
9.2 South America Fabry Disease Treatment Revenue by Application (2016-2026)
9.3 South America Fabry Disease Treatment Market Size by Country
9.3.1 South America Fabry Disease Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Fabry Disease Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Fabry Disease Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Fabry Disease Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Fabry Disease Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Fabry Disease Treatment Market Size by Country
10.3.1 Middle East & Africa Fabry Disease Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Fabry Disease Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Fabry Disease Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Fabry Disease Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Fabry Disease Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Fabry Disease Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Fabry Disease Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Fabry Disease Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Fabry Disease Treatment Revenue Market Share by Region (2021-2026)
Table 6. Sanofi S.A. Corporate Information, Head Office, and Major Competitors
Table 7. Sanofi S.A. Major Business
Table 8. Sanofi S.A. Fabry Disease Treatment Product and Solutions
Table 9. Sanofi S.A. Fabry Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Takeda Corporate Information, Head Office, and Major Competitors
Table 11. Takeda Major Business
Table 12. Takeda Fabry Disease Treatment Product and Solutions
Table 13. Takeda Fabry Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Amicus Therapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Amicus Therapeutics Inc. Major Business
Table 16. Amicus Therapeutics Inc. Fabry Disease Treatment Product and Solutions
Table 17. Amicus Therapeutics Inc. Fabry Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. ISU Abxis Co Ltd. Corporate Information, Head Office, and Major Competitors
Table 19. ISU Abxis Co Ltd. Major Business
Table 20. ISU Abxis Co Ltd. Fabry Disease Treatment Product and Solutions
Table 21. ISU Abxis Co Ltd. Fabry Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. JCR Pharmaceuticals Co Ltd. Corporate Information, Head Office, and Major Competitors
Table 23. JCR Pharmaceuticals Co Ltd. Major Business
Table 24. JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Product and Solutions
Table 25. JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Protalix Biotherapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Protalix Biotherapeutics Inc. Major Business
Table 28. Protalix Biotherapeutics Inc. Fabry Disease Treatment Product and Solutions
Table 29. Protalix Biotherapeutics Inc. Fabry Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Idorsia Pharmaceuticals Ltd. Corporate Information, Head Office, and Major Competitors
Table 31. Idorsia Pharmaceuticals Ltd. Major Business
Table 32. Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Product and Solutions
Table 33. Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Avrobio Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Avrobio Inc. Major Business
Table 36. Avrobio Inc. Fabry Disease Treatment Product and Solutions
Table 37. Avrobio Inc. Fabry Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Greenovation Biotech GmbH Corporate Information, Head Office, and Major Competitors
Table 39. Greenovation Biotech GmbH Major Business
Table 40. Greenovation Biotech GmbH Fabry Disease Treatment Product and Solutions
Table 41. Greenovation Biotech GmbH Fabry Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Moderna Therapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Moderna Therapeutics Inc. Major Business
Table 44. Moderna Therapeutics Inc. Fabry Disease Treatment Product and Solutions
Table 45. Moderna Therapeutics Inc. Fabry Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Green Cross Pharma Pte Ltd. Corporate Information, Head Office, and Major Competitors
Table 47. Green Cross Pharma Pte Ltd. Major Business
Table 48. Green Cross Pharma Pte Ltd. Fabry Disease Treatment Product and Solutions
Table 49. Green Cross Pharma Pte Ltd. Fabry Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Fabry Disease Treatment Revenue (USD Million) by Players (2019-2021)
Table 51. Global Fabry Disease Treatment Revenue Share by Players (2019-2021)
Table 52. Breakdown of Fabry Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Fabry Disease Treatment Players Head Office, Products and Services Provided
Table 54. Fabry Disease Treatment Mergers & Acquisitions in the Past Five Years
Table 55. Fabry Disease Treatment New Entrants and Expansion Plans
Table 56. Global Fabry Disease Treatment Revenue (USD Million) by Type (2016-2021)
Table 57. Global Fabry Disease Treatment Revenue Share by Type (2016-2021)
Table 58. Global Fabry Disease Treatment Revenue Forecast by Type (2021-2026)
Table 59. Global Fabry Disease Treatment Revenue by Application (2016-2021)
Table 60. Global Fabry Disease Treatment Revenue Forecast by Application (2021-2026)
Table 61. North America Fabry Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Fabry Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Fabry Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Fabry Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Fabry Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Fabry Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Fabry Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Fabry Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Fabry Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Fabry Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Fabry Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Fabry Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Fabry Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Fabry Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Fabry Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Fabry Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Fabry Disease Treatment Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Fabry Disease Treatment Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Fabry Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Fabry Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Fabry Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Fabry Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Fabry Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Fabry Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Fabry Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Fabry Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Fabry Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Fabry Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Fabry Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Fabry Disease Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Fabry Disease Treatment Picture
Figure 2. Global Fabry Disease Treatment Revenue Market Share by Type in 2020
Figure 3. Enzyme Replacement Therapy (ERT)
Figure 4. Chaperone Treatment
Figure 5. Substrate Reduction Therapy (SRT)
Figure 6. Others
Figure 7. Fabry Disease Treatment Revenue Market Share by Application in 2020
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Fabry Disease Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Fabry Disease Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Fabry Disease Treatment Revenue Market Share by Region (2016-2026)
Figure 14. Global Fabry Disease Treatment Revenue Market Share by Region in 2020
Figure 15. North America Fabry Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Fabry Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Fabry Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Fabry Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Fabry Disease Treatment Market Drivers
Figure 20. Fabry Disease Treatment Market Restraints
Figure 21. Fabry Disease Treatment Market Trends
Figure 22. Sanofi S.A. Recent Developments and Future Plans
Figure 23. Takeda Recent Developments and Future Plans
Figure 24. Amicus Therapeutics Inc. Recent Developments and Future Plans
Figure 25. ISU Abxis Co Ltd. Recent Developments and Future Plans
Figure 26. JCR Pharmaceuticals Co Ltd. Recent Developments and Future Plans
Figure 27. Protalix Biotherapeutics Inc. Recent Developments and Future Plans
Figure 28. Idorsia Pharmaceuticals Ltd. Recent Developments and Future Plans
Figure 29. Avrobio Inc. Recent Developments and Future Plans
Figure 30. Greenovation Biotech GmbH Recent Developments and Future Plans
Figure 31. Moderna Therapeutics Inc. Recent Developments and Future Plans
Figure 32. Green Cross Pharma Pte Ltd. Recent Developments and Future Plans
Figure 34. Global Fabry Disease Treatment Revenue Share by Players in 2020
Figure 35. Fabry Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Fabry Disease Treatment Revenue Market Share in 2020
Figure 37. Global Top 10 Players Fabry Disease Treatment Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Fabry Disease Treatment Revenue Share by Type in 2020
Figure 40. Global Fabry Disease Treatment Market Share Forecast by Type (2021-2026)
Figure 41. Global Fabry Disease Treatment Revenue Share by Application in 2020
Figure 42. Global Fabry Disease Treatment Market Share Forecast by Application (2021-2026)
Figure 43. North America Fabry Disease Treatment Sales Market Share by Type (2016-2026)
Figure 44. North America Fabry Disease Treatment Sales Market Share by Application (2016-2026)
Figure 45. North America Fabry Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 46. United States Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Fabry Disease Treatment Sales Market Share by Type (2016-2026)
Figure 50. Europe Fabry Disease Treatment Sales Market Share by Application (2016-2026)
Figure 51. Europe Fabry Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 52. Germany Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Fabry Disease Treatment Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Fabry Disease Treatment Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Fabry Disease Treatment Revenue Market Share by Region (2016-2026)
Figure 60. China Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Fabry Disease Treatment Sales Market Share by Type (2016-2026)
Figure 67. South America Fabry Disease Treatment Sales Market Share by Application (2016-2026)
Figure 68. South America Fabry Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Fabry Disease Treatment Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Fabry Disease Treatment Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Fabry Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Fabry Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のファブリー病治療市場 2021：企業別、地域別、種類・用途別 The Fabry Disease Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…- ファブリー病治療薬の世界市場2020年：分析と予測（～2025年） This report describes the global market size of Fabry Disease Drugs from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price is presented from 2015 to 2…
- 世界のクラッベ病治療市場規模・現状・予測（2021年-2027年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- 世界の髄膜炎菌性疾患治療市場規模・現状・予測（2021年-2027年） Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant …
- 世界の髄膜炎菌性疾患治療市場 2021：企業別、地域別、種類・用途別 The Meningococcal Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…